532482 Stock Overview
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 532482 from our risk checks.
Granules India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹529.20 |
| 52 Week High | ₹724.55 |
| 52 Week Low | ₹359.85 |
| Beta | 0.21 |
| 11 Month Change | -11.34% |
| 3 Month Change | -21.64% |
| 1 Year Change | 44.31% |
| 33 Year Change | 74.65% |
| 5 Year Change | 303.66% |
| Change since IPO | 17,250.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532482 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -7.5% | -3.0% | -3.3% |
| 1Y | 44.3% | 42.9% | 27.5% |
Return vs Industry: 532482 exceeded the Indian Pharmaceuticals industry which returned 42.9% over the past year.
Return vs Market: 532482 exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
| 532482 volatility | |
|---|---|
| 532482 Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 532482 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 532482's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 4,057 | Krishna Chigurupati | www.granulesindia.com |
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology.
Granules India Limited Fundamentals Summary
| 532482 fundamental statistics | |
|---|---|
| Market cap | ₹128.26b |
| Earnings (TTM) | ₹4.87b |
| Revenue (TTM) | ₹44.78b |
26.3x
P/E Ratio2.9x
P/S RatioIs 532482 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532482 income statement (TTM) | |
|---|---|
| Revenue | ₹44.78b |
| Cost of Revenue | ₹19.28b |
| Gross Profit | ₹25.50b |
| Other Expenses | ₹20.63b |
| Earnings | ₹4.87b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 20.10 |
| Gross Margin | 56.94% |
| Net Profit Margin | 10.88% |
| Debt/Equity Ratio | 29.5% |
How did 532482 perform over the long term?
See historical performance and comparison